Diabetes Care 47:S145S157 Jung H, Tittel SR, Schloot NC, Heitmann E, Otto T, Lebrec J, Pavel M, Lanzinger S (2023) Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: a retrospective analysis of the Diabetes Prospective Follow-Up Registry
Based on these results, the authors concluded that GPx might be contributing to the prevention of radiation-induced damages by detoxifying the hydroperoxides (Fig
with custom brackets, the archwire can fill the slot (Fig
Co-immunoprecipitation and semi-quantitative immunoblotting for the analysis of protein-protein interactions
FAQs How soon will I see results on GLPs
Mechanisms of fibroblast growth factor signaling in the ovarian follicle